• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[接种新冠疫苗的意愿——风险评估、接种经历及对治疗程序的态度]

[Willingness to be vaccinated with a COVID‑19 vaccine-risk assessment, vaccination experiences and towards treatment procedures].

作者信息

Haug Sonja, Schnell Rainer, Scharf Anna, Altenbuchner Amelie, Weber Karsten

机构信息

Institut für Sozialforschung und Technikfolgenabschätzung (IST), Regensburg Center of Health Sciences and Technology (RCHST), Ostbayerische Technische Hochschule (OTH) Regensburg, Regensburg, Deutschland.

Research Methodology Group, Universität Duisburg-Essen, Duisburg, Deutschland.

出版信息

Pravent Gesundh. 2022;17(4):537-544. doi: 10.1007/s11553-021-00908-y. Epub 2021 Nov 1.

DOI:10.1007/s11553-021-00908-y
PMID:40477663
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8559142/
Abstract

BACKGROUND

Globally, vaccination is an important preventive measure. A pronounced willingness to vaccinate is fundamental for the containment of the Coronavirus pandemic by means of vaccination coverage of society.

OBJECTIVES

The willingness to be vaccinated with a COVID‑19 (coronavirus vaccine) vaccine and its influencing factors are investigated using a random sample of the total population in Germany.

MATERIALS AND METHODS

The study is based on a random telephone sample and considers older and previously ill persons according to their proportion in population. The single-topic study on willingness to be vaccinated ( = 2014) was conducted in November/December 2020.

RESULTS

The willingness to be vaccinated in the sample is around 67%. Previous experience with vaccinations moderates the willingness to vaccinate. It increases with membership to a risk population. Belief in the efficacy of alternative healing methods and advocacy of alternative treatment procedures are associated with lower willingness to be vaccinated. Older people are more willing to be vaccinated, covarying with their assessment of higher risk in case of illness. Similarly, rejection of vaccination is associated with overestimation of side effects.

CONCLUSIONS

Willingness to vaccinate is related to vaccination experiences and attitudes towards health care procedures in general. The overestimation of the frequency of serious side effects with vaccinations indicates widespread misinformation.

摘要

背景

在全球范围内,接种疫苗是一项重要的预防措施。通过实现社会的疫苗接种覆盖率来遏制新冠疫情,民众显著的接种意愿至关重要。

目的

利用德国全体人口的随机样本,调查接种新冠疫苗的意愿及其影响因素。

材料与方法

该研究基于随机电话抽样,并根据老年人和既往患病者在人口中的比例进行考量。关于接种意愿的单项研究(样本量=2014)于2020年11月/12月开展。

结果

样本中的接种意愿约为67%。既往的疫苗接种经历会影响接种意愿。接种意愿会随着属于高危人群而增加。对替代疗法疗效的相信以及对替代治疗程序的倡导与较低的接种意愿相关。老年人更愿意接种疫苗,这与他们对患病时更高风险的评估相关。同样,拒绝接种与对副作用的高估有关。

结论

接种意愿与疫苗接种经历以及总体上对医疗程序的态度有关。对疫苗严重副作用发生频率的高估表明存在广泛的错误信息。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8197/8559142/a3412bdf7ba4/11553_2021_908_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8197/8559142/a3412bdf7ba4/11553_2021_908_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8197/8559142/a3412bdf7ba4/11553_2021_908_Fig1_HTML.jpg

相似文献

1
[Willingness to be vaccinated with a COVID‑19 vaccine-risk assessment, vaccination experiences and towards treatment procedures].[接种新冠疫苗的意愿——风险评估、接种经历及对治疗程序的态度]
Pravent Gesundh. 2022;17(4):537-544. doi: 10.1007/s11553-021-00908-y. Epub 2021 Nov 1.
2
[Factors Influencing Willingness to be Vaccinated with a COVID-19 Vaccine: Results of a CATI Population Survey].[影响新冠疫苗接种意愿的因素:一项计算机辅助电话调查的结果]
Gesundheitswesen. 2021 Oct;83(10):789-796. doi: 10.1055/a-1538-6069. Epub 2021 Aug 4.
3
[Parents' Willingness to Vaccinate with a COVID-19 Vaccine].[父母接种新冠疫苗的意愿]
Padiatr Padol. 2021;56(5):230-234. doi: 10.1007/s00608-021-00925-2. Epub 2021 Oct 1.
4
Willingness to get vaccinated against influenza, pneumococcal disease, pertussis, and herpes zoster - A pre-COVID-19 exploration among the older adult population.接种流感、肺炎球菌病、百日咳和带状疱疹疫苗的意愿——COVID-19 大流行前老年人群的探索。
Vaccine. 2023 Feb 3;41(6):1254-1264. doi: 10.1016/j.vaccine.2023.01.001. Epub 2023 Jan 4.
5
The effect of framing and communicating COVID-19 vaccine side-effect risks on vaccine intentions for adults in the UK and the USA: A structured summary of a study protocol for a randomized controlled trial.在英国和美国,针对成年人的 COVID-19 疫苗副作用风险的描述和沟通对疫苗接种意愿的影响:一项随机对照试验研究方案的结构化总结。
Trials. 2021 Sep 6;22(1):592. doi: 10.1186/s13063-021-05484-2.
6
The coverage of SARS-CoV-2 vaccination and the willingness to receive the SARS-CoV-2 variant vaccine among employees in China.中国员工对 SARS-CoV-2 疫苗的接种率和对 SARS-CoV-2 变异疫苗的接种意愿。
BMC Public Health. 2023 Mar 22;23(1):542. doi: 10.1186/s12889-023-15294-7.
7
"To Be Vaccinated or Not to Be Vaccinated": Factors Influencing COVID-19 Vaccine Hesitancy and Future Vaccination Willingness Amongst US Women of Reproductive Age.“接种还是不接种”:影响美国育龄女性对新冠疫苗犹豫及未来接种意愿的因素
Int J Womens Health. 2024 Dec 9;16:2123-2136. doi: 10.2147/IJWH.S478548. eCollection 2024.
8
A study on the willingness and influencing factors of novel coronavirus vaccination among medical personnel in North China.华北地区医务人员对新型冠状病毒疫苗接种的意愿及影响因素研究。
Hum Vaccin Immunother. 2022 Nov 30;18(5):2031775. doi: 10.1080/21645515.2022.2031775. Epub 2022 Apr 4.
9
[Willingness to get vaccinated among hospital staff in Germany: What is the role of COVID-19 conspiracy assumptions?].[德国医院工作人员的疫苗接种意愿:新冠病毒阴谋论假设起到了什么作用?]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2022 Nov;65(11):1178-1187. doi: 10.1007/s00103-022-03593-0. Epub 2022 Oct 7.
10
Knowledge, experience, and willingness to vaccinate against intestinal parasitic infections: A multi-country study in Asia.关于肠道寄生虫感染疫苗接种的知识、经验及意愿:一项在亚洲多国开展的研究
J Infect Public Health. 2025 Apr;18(4):102689. doi: 10.1016/j.jiph.2025.102689. Epub 2025 Jan 30.

本文引用的文献

1
Differences in risk perception, knowledge and protective behaviour regarding COVID-19 by education level among women and men in Germany. Results from the COVID-19 Snapshot Monitoring (COSMO) study.德国不同受教育程度的女性和男性对 COVID-19 的风险感知、知识和防护行为的差异。COVID-19 快照监测(COSMO)研究结果。
PLoS One. 2021 May 12;16(5):e0251694. doi: 10.1371/journal.pone.0251694. eCollection 2021.
2
[Risk communication in the containment of the COVID-19 pandemic: challenges and promising approaches].[新冠疫情防控中的风险沟通:挑战与可行方法]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2021 Mar;64(3):294-303. doi: 10.1007/s00103-021-03283-3. Epub 2021 Feb 9.
3
Decreasing vaccine hesitancy with extended health knowledge: Evidence from a longitudinal randomized controlled trial.
通过增加健康知识降低疫苗犹豫:来自一项纵向随机对照试验的证据。
Health Psychol. 2021 Feb;40(2):77-88. doi: 10.1037/hea0001045.
4
Once we have it, will we use it? A European survey on willingness to be vaccinated against COVID-19.一旦我们有了疫苗,会去接种吗?一项关于接种新冠疫苗意愿的欧洲调查。
Eur J Health Econ. 2020 Sep;21(7):977-982. doi: 10.1007/s10198-020-01208-6.
5
Resurgence of Measles in Europe: A Systematic Review on Parental Attitudes and Beliefs of Measles Vaccine.欧洲麻疹卷土重来:关于麻疹疫苗的父母态度和信念的系统评价。
J Epidemiol Glob Health. 2020 Mar;10(1):46-58. doi: 10.2991/jegh.k.191117.001.
6
[Postvaccinal complications and management of suspected cases].[疫苗接种后并发症及疑似病例的管理]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2019 Apr;62(4):450-461. doi: 10.1007/s00103-019-02913-1.
7
Beyond confidence: Development of a measure assessing the 5C psychological antecedents of vaccination.超越信心:评估疫苗接种 5C 心理前因的测量工具的开发。
PLoS One. 2018 Dec 7;13(12):e0208601. doi: 10.1371/journal.pone.0208601. eCollection 2018.
8
The public health value of vaccines beyond efficacy: methods, measures and outcomes.疫苗超出效力之外的公共卫生价值:方法、措施与结果
BMC Med. 2017 Jul 26;15(1):138. doi: 10.1186/s12916-017-0911-8.
9
Barriers of Influenza Vaccination Intention and Behavior - A Systematic Review of Influenza Vaccine Hesitancy, 2005 - 2016.流感疫苗接种意愿与行为的障碍——2005 - 2016年流感疫苗犹豫情况的系统评价
PLoS One. 2017 Jan 26;12(1):e0170550. doi: 10.1371/journal.pone.0170550. eCollection 2017.
10
New viral vaccines.新型病毒疫苗。
Virology. 2006 Jan 5;344(1):240-9. doi: 10.1016/j.virol.2005.09.057.